Key Metrics
CiteScore 

5.9
Eigenfactor 

0.001 - 0.005
H-Index 

57
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Cardiovascular Drugs
American Journal of Cardiovascular Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Cardiovascular Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Cardiovascular Drugs
Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".
- 18 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Comment on: "Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide".
- 18 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.
- 16 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
- 9 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
- 30 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
- 29 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".
- 18 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Comment on: "Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide".
- 18 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.
- 16 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
- 9 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
- 30 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
- 29 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions